Literature DB >> 31062140

Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances.

Ming Chen1, Zhang Zhang2, Min Yang1, Shi-Ting Li3.   

Abstract

PURPOSE: To compare the different levels of inflammatory markers, hormone markers, and radiological appearances between PCACP with and without calcification so as to explore the relationships between these markers and calcification.
METHODS: The inflammatory markers, hormone markers, and radiological appearances were compared not only between PCACP with and without calcification, but also among its different forms of calcification. The receiver operating characteristic (ROC) curve was performed to evaluate the diagnostic significance of all markers between these groups.
RESULTS: It was showed that the white blood cell (WBC) count, neutrophil count, monocyte count, prognostic nutritional index (PNI), prolactin (PRL), and T1WI signal of cysts were higher in PCACP with calcification than in PCACP without calcification. The neutrophil count was significantly higher in PCACP with eggshell calcification than in other groups. The PCACP with mixed calcification had the highest PRL level in all kinds of PCACP with calcification. Only the area under curve (AUC) values of neutrophil count and PRL level were greater than 0.8.
CONCLUSION: It is found that inflammation and hormone are related to PCACP's calcification. High neutrophil count and PRL level may indicate possible calcification tendency in PCACP. Improved intracystic therapies based on these results may help to inhibit the formation of calcification in PCACP in future.

Entities:  

Keywords:  Calcification; Craniopharyngioma; Cyst

Mesh:

Substances:

Year:  2019        PMID: 31062140     DOI: 10.1007/s00381-019-04178-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  44 in total

Review 1.  The pathogenesis of craniopharyngiomas.

Authors:  Vikram C Prabhu; Henry G Brown
Journal:  Childs Nerv Syst       Date:  2005-06-18       Impact factor: 1.475

2.  Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.

Authors:  D M Shin; F R Khuri; B Murphy; A S Garden; G Clayman; M Francisco; D Liu; B S Glisson; L Ginsberg; V Papadimitrakopoulou; J Myers; W Morrison; A Gillenwater; K K Ang; S M Lippman; H Goepfert; W K Hong
Journal:  J Clin Oncol       Date:  2001-06-15       Impact factor: 44.544

Review 3.  Craniopharyngioma.

Authors:  John A Jane; Edward R Laws
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

4.  Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.

Authors:  Seema Singh; Anguraj Sadanandam; Kalyan C Nannuru; Michelle L Varney; Rosemary Mayer-Ezell; Richard Bond; Rakesh K Singh
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

5.  Expression of interleukin-6 in human craniopharyngiomas: a possible inducer of tumor-associated inflammation.

Authors:  Masanao Mori; Hideo Takeshima; Jun-ichi Kuratsu
Journal:  Int J Mol Med       Date:  2004-10       Impact factor: 4.101

6.  Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.

Authors:  Narattaphol Charoenphandhu; Jarinthorn Teerapornpuntakit; Methajit Methawasin; Kannikar Wongdee; Kanogwun Thongchote; Nateetip Krishnamra
Journal:  Can J Physiol Pharmacol       Date:  2008-05       Impact factor: 2.273

Review 7.  Systemic inflammation, nutritional status and survival in patients with cancer.

Authors:  Donald C McMillan
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-05       Impact factor: 4.294

8.  Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization.

Authors:  Dutmanee Seriwatanachai; Nateetip Krishnamra; J P T M van Leeuwen
Journal:  J Cell Biochem       Date:  2009-07-01       Impact factor: 4.429

9.  Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy.

Authors:  L Edwards; B Berman; R P Rapini; D A Whiting; S Tyring; H T Greenway; S P Eyre; D J Tanner; E L Taylor; E Peets
Journal:  Arch Dermatol       Date:  1992-11

10.  Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.

Authors:  Karen H Kim; Regina M Yavel; Victoria L Gross; Neil Brody
Journal:  Dermatol Surg       Date:  2004-01       Impact factor: 3.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.